Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

Phillips GL, Wolff SN, Herzig RH, Lazarus HM, Fay JW, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, et al.

Blood. 1989 Jun;73(8):2086-92.

2.

The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation.

Phillips GL, Fay JW, Herzig RH, Lazarus HM, Wolff SN, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, et al.

Blood. 1990 Feb 15;75(4):831-8.

5.

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT.

Am J Med. 1991 Dec;91(6):605-11.

PMID:
1750430
6.

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM.

Bone Marrow Transplant. 2001 Feb;27(4):387-96.

7.

High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission.

Nademanee A, Molina A, Fung H, Stein A, Parker P, Planas I, O'Donnell MR, Snyder DS, Kashyap A, Spielberger R, Bhatia R, Krishnan A, Sniecinski I, Vora N, Slovak M, Dagis A, Niland JC, Forman SJ.

Biol Blood Marrow Transplant. 1999;5(5):292-8.

8.

Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.

Kahn ST, Flowers CR, Lechowicz MJ, Hollenbach K, Johnstone PA.

Cancer J. 2005 Sep-Oct;11(5):425-31.

PMID:
16259874
9.

[High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].

Zhou SY, Shi YK, He XH, Han XH, Liu P, Yang JL, Zhou AP, Feng FY.

Ai Zheng. 2002 Apr;21(4):405-8. Chinese.

PMID:
12452021
10.

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.

Reece DE, Connors JM, Spinelli JJ, Barnett MJ, Fairey RN, Klingemann HG, Nantel SH, O'Reilly S, Shepherd JD, Sutherland HJ, et al.

Blood. 1994 Mar 1;83(5):1193-9.

11.

The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients.

Chopra R, McMillan AK, Linch DC, Yuklea S, Taghipour G, Pearce R, Patterson KG, Goldstone AH.

Blood. 1993 Mar 1;81(5):1137-45.

13.

High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.

O'Brien ME, Milan S, Cunningham D, Jones AL, Nicolson M, Selby P, Hickish T, Hill M, Gore ME, Viner C.

Br J Cancer. 1996 May;73(10):1272-7.

14.
15.

Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.

Wiernik PH, Dutcher JP, Einzig AI, Sparano J, Frank M, Friedenberg W.

Cancer J Sci Am. 1998 Jul-Aug;4(4):254-60.

PMID:
9689984
16.
17.

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.

Mundt AJ, Sibley G, Williams S, Hallahan D, Nautiyal J, Weichselbaum RR.

Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):261-70.

PMID:
7673013
18.

Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.

Vlachaki MT, Hagemeister FB, Fuller LM, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):593-9.

PMID:
9231684
19.

Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.

Phillips GL, Reece DE.

Clin Haematol. 1986 Feb;15(1):151-66. Review.

PMID:
3516487
20.

Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group.

Sureda A, Mataix R, Hernández-Navarro F, Jarque I, Lahuerta JJ, Tomás JF, Brunet S, Caballero D, Conde E, León A, Fernández MN, López A, Maldonado J, Bengoechea E, Callís M, Carrera D, García-Conde J, García-Laraña J, Moraleda JM, Morey M, Rifón J, Sierra J, Torres A, Domingo-Albós A.

Bone Marrow Transplant. 1997 Aug;20(4):283-8.

Supplemental Content

Support Center